Skip to content
FrontierPicks

Watching

SMG · Scotts Miracle-Gro

Conviction · Medium · more likely to lead the S&P 500 over the next three months, by a modest margin

Wrong if: a daily close below $61.80

Note written ·

Price against the kill line

3.3% clear of its kill line on the 13 November 2026 close.

How to read this

The red mark is the price level of the published kill line: a close through it (a weekly close, on a weekly line) would prove the research note wrong on price. The dot is where the stock closed on 13 November 2026; a dot left of the mark has closed through its line.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

SMGScotts Miracle-Gro
$61.80
$63.84
3.3%clear of the line

Three months against the kill line

SMG daily closes from 17 August 2026 to 13 November 2026, last $63.84, against its kill line: a daily close below $61.80. 17 August 2026: $58.5618 August 2026: $58.9119 August 2026: $60.4720 August 2026: $60.4721 August 2026: $61.0124 August 2026: $60.6925 August 2026: $62.6126 August 2026: $61.3527 August 2026: $60.5928 August 2026: $60.4331 August 2026: $59.801 September 2026: $59.102 September 2026: $59.973 September 2026: $59.294 September 2026: $59.478 September 2026: $57.539 September 2026: $56.9010 September 2026: $56.1611 September 2026: $56.4714 September 2026: $55.9115 September 2026: $56.0916 September 2026: $54.7917 September 2026: $53.9318 September 2026: $52.3621 September 2026: $51.4222 September 2026: $52.6823 September 2026: $52.8324 September 2026: $51.1325 September 2026: $50.8928 September 2026: $48.4429 September 2026: $49.5030 September 2026: $50.111 October 2026: $50.022 October 2026: $49.025 October 2026: $49.106 October 2026: $50.527 October 2026: $49.408 October 2026: $50.439 October 2026: $49.8612 October 2026: $49.9413 October 2026: $50.1014 October 2026: $49.7215 October 2026: $54.2516 October 2026: $54.5719 October 2026: $54.3920 October 2026: $55.8621 October 2026: $55.9322 October 2026: $59.1523 October 2026: $59.2926 October 2026: $58.8327 October 2026: $59.3628 October 2026: $59.6629 October 2026: $61.8730 October 2026: $62.242 November 2026: $65.133 November 2026: $61.804 November 2026: $67.195 November 2026: $66.386 November 2026: $64.719 November 2026: $66.3410 November 2026: $65.1311 November 2026: $65.0412 November 2026: $63.7413 November 2026: $63.84

Daily closes, to . Red: the kill line, a daily close below $61.80, on record since 10 November 2026. The shares are up 9.0% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close below $61.80, the 3 November 2026 close before the fiscal 2026 report, which would erase the results-day gain. A cut to the $4.70 to $4.90 fiscal 2027 adjusted earnings per share guidance would also break the case.

Research onlyNot in the portfolio.

The portfolio's record →

Key figures from the filings · Materials

Quarter to 27 June 2026, filed 5 August 2026; valuation at the 13 November 2026 close

Revenue, latest quarter ($M)
1,172
Revenue, change on a year (%)
+1.1
Gross margin (%)
31.2
Operating margin (%)
14.5
Free cash flow, four quarters ($M)
263
Net cash, cash less debt ($M)
−2,086
Price to earnings (×)
50.3
Free-cash-flow yield (%)
7.1
All filed numbers

What Scotts Miracle-Gro reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 1,172 +1.1 31.2 14.5
first filed 1,460 +5.0 41.8 27.5
first filed 354 −3.3 25.0 −6.2
first filed restated 1,159 −3.6 32.1 19.1
first filed restated 1,390 −8.9 39.0 25.2
Income Quarter to 27 June 2026, filed 5 August 2026
Pre-tax income ($M) 155
Net income ($M) four quarters: 73.9 112
Diluted shares, change on a year (%) against the quarter to 28 June 2025 +1.0
Cash flow Four quarters to 27 June 2026, filed 5 August 2026
Operating cash flow ($M) 369
Capital spending ($M) 106
Free cash flow ($M) 263
Balance sheet At 27 June 2026, filed 5 August 2026
Cash and short-term investments ($M) 27.7
Debt ($M) non-current long-term debt plus current maturities 2,113
Net cash, cash less debt ($M) −2,086
Deferred revenue ($M) Not reported
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) 713
Inventory ($M) 481
Shareholders' equity ($M) −209
Valuation At the 13 November 2026 close, filed figures to 5 August 2026
Market value ($M) 3,717
Enterprise value, market value plus net debt ($M) 5,802
Enterprise value to sales (×) Not available
Enterprise value to operating income (×) Not available
Price to earnings (×) 50.3
Price to book value (×) Not meaningful
Free-cash-flow yield (%) 7.1

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 9.8% of shares outstanding sold short, 5.4 days of average trading to cover, +7.4% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $176K
12 monthsfrom $50K $5.7M

The thesis

Scotts Miracle-Gro's margin recovery gives the shares a modest edge over the market. Its fiscal 2027 guidance of $4.70 to $4.90 in adjusted earnings per share (EPS) matches or beats the $4.71 consensus Benzinga reported on 4 November 2026, even with about $100 million of expected commodity inflation. The fiscal first-quarter report, expected in late January 2027, and spring retail sales will show whether the pricing plan holds.

The case rests on price, cost and debt reduction. Sales growth is not part of it. Fiscal 2026 adjusted EPS from continuing operations rose 18% to $4.48, above the $4.30 to $4.45 guidance, while fourth-quarter sales fell 11% (company release, 4 November 2026). With the North American Hawthorne hydroponics business sold on 8 April 2026, the company is almost entirely a US consumer lawn and garden business. US Consumer accounted for $3,017.6 million of fiscal 2026 net sales of $3,288.9 million.

The shares closed at $63.74 on 12 November 2026, down from $66.34 on 9 November 2026. They remain above the 3 November 2026 close, the last session before results, so the results-day gain still holds. No company filing, guidance change or analyst action since the 5 November 2026 target raises has changed the earnings case.

Bullish and bearish views on The Scotts Miracle-Gro Company

The bull case on The Scotts Miracle-Gro Company (SMG), in brief: guidance matched or beat consensus. The bear case: fourth-quarter sales missed.

Bull case

  • Guidance matched or beat consensus. The company guided fiscal 2027 sales to $3.355 billion to $3.420 billion against a $3.361 billion estimate, and adjusted EPS to $4.70 to $4.90 against $4.71 (Benzinga, 4 November 2026).
  • Margins widened in fiscal 2026. Adjusted gross margin rose 80 basis points to 32.4% (company release, 4 November 2026). On the 4 November 2026 call, management guided to further expansion in fiscal 2027, likely at the low end of a 50 to 100 basis point range.
  • Costs are locked in earlier than usual. About 55% of cost of goods sold is locked, against a typical 40% at this point in the year. More than 80% of urea is locked and more than 50% of diesel is hedged (4 November 2026 call).
  • Price rises and savings offset inflation. Management plans an average price rise of about 4%, or about 2% after expected lost volume, plus at least $35 million of supply chain savings (4 November 2026 call).
  • Cash flow is paying down debt. Free cash flow was $278.4 million in fiscal 2026, and $250 million of 5.250% notes were redeemed on 11 September 2026. Net leverage, meaning net debt relative to adjusted earnings, improved 0.21 times to 3.89 times (company release, 4 November 2026).
  • Analysts raised targets after the report. UBS raised its target to $77 from $70, keeping a Buy rating. Wells Fargo raised its target to $76 from $71, keeping an Overweight rating. Both moves came on 5 November 2026. Wells Fargo had already raised its target from $60 to $71 on 2 November 2026.

Bear case

  • Fourth-quarter sales missed. Sales of $302.9 million fell 11% and missed the $306.1 million estimate. The adjusted loss widened to $2.16 a share from $1.97, though it was smaller than the $2.21 loss analysts expected (company release; Benzinga, 4 November 2026).
  • Operating earnings trailed guidance. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) rose 2% to $579.9 million. The company had reaffirmed mid single-digit growth as recently as 15 September 2026.
  • Consumer purchases are barely growing. Branded point-of-sale (POS) dollars, a measure of retail sales to consumers, rose about 1% in fiscal 2026, and lawns fell 3% (4 November 2026 call). E-commerce POS dollars rose 24% and reached 13% of sales, the one strong area.
  • Retailers hold more stock than a year ago. The largest retailers ended fiscal 2026 with inventory up low single digits. Management plans for a low single-digit sales headwind from this. CEO Nate Baxter attributed about half of the inventory effect to slower consumer purchases (4 November 2026 call).
  • An acquisition props up guided growth. The $55 million Black Kow purchase, completed on 29 October 2026, adds 1% to 2% to fiscal 2027 sales growth, against a guided total of 2% to 4%. That leaves little organic growth.
  • Leverage is still high. Net leverage was 3.89 times at 30 September 2026. Management does not expect to reach its 3.0 to 3.5 times target until fiscal 2029 (company release, 4 November 2026).
  • A director sold after the results gain. Director David C. Evans sold 2,655 shares on the open market at $66.42 on 9 November 2026 (SEC Form 4 filed 12 November 2026). The sale is small, and it is the only open-market insider trade on file since the report.

Price setup

The shares closed at $63.74 on 12 November 2026, up 5.7% over three months on adjusted daily closes. That close is 15.4% below the 52-week intraday high of $75.34, set on 17 July 2026. It is well above the 52-week closing low of $48.44 from 28 September 2026.

The last close sits above both the 50-day moving average of $56.10 and the 200-day moving average of $61.15, as of 12 November 2026. The 3 November 2026 close, the session before results, lies just above the 200-day average. A fall below both would erase the post-results gain and return the shares to their pre-report range. The analyst targets of $76 (Wells Fargo) and $77 (UBS) sit near the July high.

The shares gave back part of the results-day move between 9 November 2026 and 12 November 2026 with no company news in that window. Insider activity since the report consists of annual stock awards on 28 October 2026, including 23,872 shares to CEO Nathan Baxter, and the one director sale (SEC Form 4 filings). The fiscal fourth quarter normally posts a loss, so the shares trade on guidance and spring-season expectations more than on the latest quarter.

Catalysts ahead

  • 20 November 2026: Ex-dividend date for the $0.66 quarterly dividend declared on 3 November 2026. It shows the payout continuing while the company directs free cash flow to debt reduction.
  • ~25 November 2026 (est.): Fiscal 2026 annual report on Form 10-K. It gives fuller disclosure on customer concentration and the debt schedule behind the deleveraging case.
  • ~27 January 2027 (est.): Fiscal first-quarter 2027 report, date not yet announced. It is the first check on pricing, retailer inventory and management's expectation of flat first-half sales within full-year guidance.

What would change the view

A daily close below $61.80, the 3 November 2026 close before the fiscal 2026 report, which would erase the results-day gain. A cut to the $4.70 to $4.90 fiscal 2027 adjusted earnings per share guidance would also break the case.

The risks this note tracks, each with what would confirm it:

  • Retailers cut inventory further than management's assumption of roughly flat levels, reducing shipments in the first half of fiscal 2027. Confirmed by: management reporting retailer inventory below fiscal 2026 levels, or first-half sales below last year, at the next quarterly report.
  • Price rises of about 4% cost more volume than the roughly half that management assumes. Confirmed by: branded point-of-sale units or dollars declining in the fiscal 2027 quarterly reports, or lower net pricing guidance.
  • Commodity inflation exceeds about $100 million and absorbs the expected gross margin expansion. Confirmed by: management raising its commodity headwind estimate or withdrawing gross margin expansion from fiscal 2027 guidance.
  • Debt reduction slows, keeping net leverage away from the 3.0 to 3.5 times target for fiscal 2029. Confirmed by: fiscal 2027 free cash flow guidance falling below about $275 million, or year-end net leverage above 3.89 times.

What it trades with

Since the Hawthorne divestiture, the shares move mainly with US lawn and garden spending and with input costs, chiefly urea and diesel, which management partly locks in ahead of time. Results depend on the spring selling season and on orders from a small number of large retail customers, so results from big-box home and garden retailers are relevant to Scotts. Trading tied to cannabis has faded now that Hawthorne is reported as a discontinued operation. Interest rates matter through the debt load, with net leverage at 3.89 times at fiscal year-end.

The evidence, claim by claim (8)
  1. Fiscal 2026 net sales were $3,288.9 million, up 1%, and adjusted EPS from continuing operations was $4.48, up 18%. Company news release, Form 8-K, 4 November 2026 · as of
  2. Fiscal fourth-quarter net sales were $302.9 million, down 11% from $340.1 million, and missed the $306.1 million estimate. Company news release, Form 8-K; Benzinga, 4 November 2026 · as of
  3. Fiscal 2027 guidance calls for net sales growth of 2% to 4%, adjusted EPS of $4.70 to $4.90 and free cash flow of about $275 million. Company news release, Form 8-K, 4 November 2026 · as of
  4. Management expects about $100 million of commodity headwinds in fiscal 2027, with about 55% of cost of goods sold locked, urea over 80% locked and diesel over 50% hedged. 4 November 2026 earnings call transcript · as of
  5. Net leverage was 3.89 times at fiscal year-end, improved by 0.21 times, against a target of 3.0 to 3.5 times by fiscal 2029. Company news release, Form 8-K, 4 November 2026 · as of
  6. Inventory at the largest retailers ended fiscal 2026 up low single digits, compared with high single digits described on the 29 July 2026 call. 4 November 2026 and 29 July 2026 earnings call transcripts · as of
  7. UBS raised its price target to $77 from $70 and Wells Fargo raised its target to $76 from $71, both keeping positive ratings. Benzinga and fiscal.ai analyst items, 5 November 2026 · as of
  8. Director David C. Evans sold 2,655 shares on the open market at $66.42. SEC Form 4 filed 12 November 2026 · as of

Sources

Related · shared themes

See also · stocks to watch

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X